Why Canada’s Pancreatic Cancer Survival Rates Are a National Disgrace

Canada's Pancreatic Cancer CrisisThe Team Heather Audio Series presents a critical examination of Canada's pancreatic cancer situation, based on the article Why Canada's Pancreatic Cancer Survival Rates are a National Disgrace. This episode offers listeners an in-depth look at the challenges facing people living with pancreatic cancer in Canada and the urgent need for change.Key TopicsSurvival Rates: The series explores Canada's 10% five-year survival rate for pancreatic cancer, comparing it to progress in other countries.Urban vs. Rural Disparities: Listeners learn about the significant differences in care and outcomes between urban and rural patients.Clinical Trial Access: The audio content discusses the limited availability of precision medicine trials, especially outside major provinces.Regulatory Challenges: Examines delays in drug approvals and funding, focusing on cases like Onivyde.Comparison with U.S. Progress: Contrasts Canada's situation with advancements in the United States, highlighting organizations like PANCAN.Current Initiatives: Explores efforts like the CRAFT Framework and Health Canada's Clinical Trial Modernization.Call to Action: Concludes with a call for increased funding, expanded trial access, and greater patient support. But we’re not just here to complain. We’re in the final processes of consulting with other Canadian Advocacy Organizations to fine-tune our petition that will be formally submitted to the House of Commons on World Pancreatic Cancer Day, November 24. Until that time, we’re gathering signatures on Change.orgWhy Listen?Comprehensive Overview: Gain a thorough understanding of Canada's pancreatic cancer landscape. Actionable Information: Learn how to get involved and make a difference. Accessibility: Absorb crucial information in an easy-to-digest audio format.